Skip to content

Local Infiltration Analgesia vs Adductor Canal Block for Analgesia After Anterior Cruciate Ligament Reconstruction

Postoperative Analgesic Efficacy of Local Infiltration Analgesia Versus Adductor Canal Block After Anterior Cruciate Ligament Reconstruction: A Randomised Controlled Double-blinded Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02524652
Enrollment
104
Registered
2015-08-17
Start date
2015-09-30
Completion date
2018-03-31
Last updated
2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infiltration, Regional Anesthesia Morbidity, Rupture of Anterior Cruciate Ligament

Brief summary

Early rehabilitation after anterior cruciate ligament reconstruction is of paramount importance and requires optimal pain control based on a multimodal concept, including injection of local anaesthetics. Regarding this latter, different options have emerged recently such as the adductor canal block, performed before the surgery by the anaesthesiologist or the infiltration of the articulation performed by the surgeon at the of the intervention. No trial has compared these two approaches. As practice of medicine should be based on evidence, we decided to undertake this randomised controlled trial where we compared the adductor canal block with the local infiltration analgesia technique in terms of pain and functional outcomes

Detailed description

Patients scheduled to undergo anterior cruciate ligament reconstruction under general anaesthesia will be randomly allocated to two groups: local infiltration analgesia or adductor canal block. The local infiltration analgesia will be performed by the surgeon at the end of surgery with 20 mLs of ropivacaine 0.5%. The adductor canal block will be performed by the anaesthesiologist under ultrasound guidance after the surgery, before awaking the patient, using the same solution (20 mLs ropivacaine 0.5%) Postoperative analgesia will include intravenous patient-controlled analgesia of morphine (settings 1 mg/ml, 2 ml/10 minutes, 40 mg/4 hours), ibuprofen (3x400 mg) and acetaminophen (4x1000 mg). A research assistant and a physiotherapist, both blinded to the group allocation, will collect pain and rehabilitation data, respectively.

Interventions

DRUGRopivacaine 0.5% 20 mLs

Injection of the local anesthetic at the end of surgery, either in the surgical sites by the surgeon, or in the adductor canal block by the anesthesiologist under ultrasound guidance.

Sponsors

Centre Hospitalier Universitaire Vaudois
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* patients from 18 to 50 years old scheduled to undergo anterior cruciate ligament reconstruction

Exclusion criteria

* peripheral neuropathy * pre-existing femoral neuropathy * diabetes mellitus * alcoholism * drug addiction * cancer with chemotherapy * chronic pain state

Design outcomes

Primary

MeasureTime frame
Total morphine consumption (mg)24 h postoperatively

Secondary

MeasureTime frameDescription
Pain scores (numeric rating scale, 0-10) at rest and on movement2 h postoperatively
Postoperative nausea and vomiting (yes/no)24 h postoperatively
Pruritus (yes/no)24 h postoperatively
Active flexion24 h postoperativelyFlexion of the knee by the patient measured in degrees
Total morphine consumption (mg)2 h postoperatively
Distance walked (meters)24 h postoperatively
Anterior Cruciate Ligament - Return to Sport after Injury scale4 months postoperatively
Anterior cruciate ligament -Return to Sport after Injury scale8 months postoperatively
International Knee Documentation Committee score4 months postoperatively
Quadriceps muscle strength (numeric scale, 1-5)24 h postoperatively

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026